Given melatonin’s suppression of the autotaxin gene expression alongside its pleiotropic effects in the liver and antipruritic effect in atopic dermatitis, we designed a pilot clinical trial to assess its effects on pruritus associated with CLD. The gene discussed is ENPP2; the disease is atopic eczema.